跳至主要内容
临床试验/CTRI/2021/07/035223
CTRI/2021/07/035223尚未招募2 期

Prophylactic pirfenidone for prevention of radiation induced pneumonitis in patients with Lung cancer (PROPER study) - PROPER

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion criteria
  • 1. 18-70 years old, male or female
  • 2. General condition assessment, ECOG score of 0-1
  • 3. Pathological diagnosis of lung cancer, with non-small cell lung cancer (NSCLC) staging IIIA or IIIB, and small cell lung cancer (SCLC)
  • 4. Candidate for radical treatment with radiation therapy with or without chemotherapy
  • 5. Expected survival at 6 months or more

排除标准

  • Exclusion criteria
  • 1. Unable to perform or any contra-indications for performing PFT
  • 2. Concurrent / active pulmonary infection
  • 3. Associated with other serious diseases: such as occurred within 6 months of myocardial infarction, uncontrolled diabetes etc.
  • 4. Chronic liver disease/cirrhosis
  • 5. With active peptic ulcer
  • 6. Unwilling to take radiation therapy at TMH
  • 7. Pregnant women and patients with known psychiatric/psychological disorders

研究者

相似试验